# Ventavis® Registry Protocol

> **NCT00902603** · — · TERMINATED · sponsor: **Actelion** · enrollment: 148 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Commercial Ventavis® (iloprost)

## Key facts

- **NCT ID:** NCT00902603
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 148 (ACTUAL)
- **Why stopped:** low enrollment and difficulty recruiting eligible patients in adequate time
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00902603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00902603, "Ventavis® Registry Protocol". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00902603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*